133 related articles for article (PubMed ID: 35731051)
1. Extranodal NK/T-cell lymphoma: a case report of renal insufficiency during PD1 inhibitor treatment.
Hu HY; Xie XX; Tan ST; Fan X; He J
Eur Rev Med Pharmacol Sci; 2022 Jun; 26(11):3827-3831. PubMed ID: 35731051
[TBL] [Abstract][Full Text] [Related]
2. The expression and clinical significance of programmed cell death receptor 1 and its ligand in tumor tissues of patients with extranodal nasal NK/T cell lymphoma.
Feng Y; Feng X; Jing C; Yu X; Zheng Y; Xu C
Sci Rep; 2022 Jan; 12(1):36. PubMed ID: 34996890
[TBL] [Abstract][Full Text] [Related]
3. Predicting treatment response of patients with extranodal natural killer/T-cell lymphoma based on levels of PD-L1 mRNA and soluble PD-L1.
Feng Y; Jing C; Yu X; Cao X; Xu C
Hematol Oncol; 2020 Oct; 38(4):467-477. PubMed ID: 32515093
[TBL] [Abstract][Full Text] [Related]
4. Expression of programmed cell death 1 and programmed cell death ligand 1 in extranodal NK/T-cell lymphoma, nasal type.
Jo JC; Kim M; Choi Y; Kim HJ; Kim JE; Chae SW; Kim H; Cha HJ
Ann Hematol; 2017 Jan; 96(1):25-31. PubMed ID: 27696202
[TBL] [Abstract][Full Text] [Related]
5. Programmed Cell Death 1 and Programmed Cell Death Ligands in Extranodal Natural Killer/T Cell Lymphoma: Expression Pattern and Potential Prognostic Relevance.
Muhamad H; Suksawai N; Assanasen T; Polprasert C; Bunworasate U; Wudhikarn K
Acta Haematol; 2020; 143(1):78-88. PubMed ID: 31330525
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathogenic pathways in extranodal NK/T cell lymphoma.
de Mel S; Hue SS; Jeyasekharan AD; Chng WJ; Ng SB
J Hematol Oncol; 2019 Apr; 12(1):33. PubMed ID: 30935402
[TBL] [Abstract][Full Text] [Related]
7. First-line immunotherapy with anti-PD-1 antibody for extranodal NK/T-cell lymphoma: A retrospective study.
Wang X; Wen L; Liao J; Feng Y; Li Y; Zhou Z; Zhou C; Huang H
Br J Haematol; 2023 Aug; 202(4):812-824. PubMed ID: 37394245
[TBL] [Abstract][Full Text] [Related]
8. Expression of programmed cell death ligand 1 (PD-L1) in advanced stage EBV-associated extranodal NK/T cell lymphoma is associated with better prognosis.
Kim WY; Jung HY; Nam SJ; Kim TM; Heo DS; Kim CW; Jeon YK
Virchows Arch; 2016 Nov; 469(5):581-590. PubMed ID: 27595782
[TBL] [Abstract][Full Text] [Related]
9. Atezolizumab in combination with intrathecal chemotherapy and radiation for treatment of isolated cerebral nervous system relapse in a patient with extranodal NK/T cell lymphoma: a case report.
Lipsitt AE; Hung JY; Langevin AM
J Med Case Rep; 2021 Mar; 15(1):102. PubMed ID: 33663601
[TBL] [Abstract][Full Text] [Related]
10. GM-CSF mediates immune evasion via upregulation of PD-L1 expression in extranodal natural killer/T cell lymphoma.
Rong QX; Wang F; Guo ZX; Hu Y; An SN; Luo M; Zhang H; Wu SC; Huang HQ; Fu LW
Mol Cancer; 2021 May; 20(1):80. PubMed ID: 34051805
[TBL] [Abstract][Full Text] [Related]
11. Pembrolizumab in newly diagnosed EBV-negative extranodal natural killer/T-cell lymphoma: A case report.
Asif S; Begemann M; Bennett J; Fatima R; Masood A; Raza S
Mol Clin Oncol; 2019 Mar; 10(3):397-400. PubMed ID: 30847181
[TBL] [Abstract][Full Text] [Related]
12. Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases.
Haverkos BM; Pan Z; Gru AA; Freud AG; Rabinovitch R; Xu-Welliver M; Otto B; Barrionuevo C; Baiocchi RA; Rochford R; Porcu P
Curr Hematol Malig Rep; 2016 Dec; 11(6):514-527. PubMed ID: 27778143
[TBL] [Abstract][Full Text] [Related]
13. CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China.
Feng Y; Rao H; Lei Y; Huang Y; Wang F; Zhang Y; Xi S; Wu Q; Shao J
Chin J Cancer; 2017 May; 36(1):43. PubMed ID: 28486951
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological study of pulmonary extranodal nature killer/T-cell lymphoma, nasal type and literature review.
Ding W; Wang J; Zhao S; Yang Q; Sun H; Yan J; Gao L; Yao W; Zhang W; Liu W
Pathol Res Pract; 2015 Jul; 211(7):544-9. PubMed ID: 25953340
[TBL] [Abstract][Full Text] [Related]
15. Primary small intestinal extranodal NK/T cell lymphoma, nasal type with kidney involvement: a rare case report and literature review.
Mao S; Diao C; Cao L
Diagn Pathol; 2022 Oct; 17(1):75. PubMed ID: 36199094
[TBL] [Abstract][Full Text] [Related]
16. Extranodal NK/T-cell lymphoma in Tunisia: clinicopathological features, immunophenotype and EBV infection.
Missaoui N; Mestiri S; Bouriga A; Abdessayed N; Belakhdher M; Ghammem M; Abdelkefi M; Mokni M; Hmissa S
J Egypt Natl Canc Inst; 2019 Oct; 31(1):1. PubMed ID: 32372136
[TBL] [Abstract][Full Text] [Related]
17. [Extra-nodal NK/T-cell lymphoma, nasal-type, revealed by cutaneous and ocular involvement].
Marzouki-Zerouali A; Charbit L; Mitcov M; Violon F; Schmutz JL; Moawad S; Bursztejn AC
Ann Dermatol Venereol; 2019 Oct; 146(10):626-633. PubMed ID: 31371036
[TBL] [Abstract][Full Text] [Related]
18. Malignant effusions from extranodal NK/T-cell lymphomas are frequently of anaplastic morphology with azurophilic granules and of T-cell lineage.
Liu CY; Chen BJ; Chuang SS;
Diagn Cytopathol; 2020 May; 48(5):453-463. PubMed ID: 32020785
[TBL] [Abstract][Full Text] [Related]
19. Combined immune checkpoint blockade and radiotherapy induces durable remission in relapsed natural killer/T-cell lymphoma: a case report and review of the literature.
McGehee E; Patel H; Pearson C; Clements K; Jaso JM; Chen W; Callan A; Desai N; Ramakrishnan Geethakumari P
J Med Case Rep; 2021 Apr; 15(1):221. PubMed ID: 33926575
[TBL] [Abstract][Full Text] [Related]
20. [Extranodal NK/T-cell lymphoma, nasal-type, revealed by cutaneous breast involvement].
Fréling E; Granel-Brocard F; Serrier C; Ortonne N; Barbaud A; Schmutz JL
Ann Dermatol Venereol; 2015 Feb; 142(2):104-11. PubMed ID: 25554664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]